Guerbet SA (EPA:GBT)

France flag France · Delayed Price · Currency is EUR
9.08
-0.22 (-2.37%)
Apr 2, 2026, 5:35 PM CET
Market Cap114.55M -66.4%
Revenue (ttm)798.67M -6.2%
Net Income-108.33M
EPS-8.59
Shares Out12.62M
PE Ration/a
Forward PE10.10
Dividendn/a
Ex-Dividend Daten/a
Volume30,962
Average Volume26,080
Open9.60
Previous Close9.30
Day's Range8.95 - 9.60
52-Week Range8.01 - 23.70
Beta0.91
RSI33.41
Earnings DateMar 11, 2026

About Guerbet

Guerbet SA engages in the development and marketing of contrast agents, medical devices, and related solutions in France and internationally. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine; Elucirem, a macrocyclic gadolinium-based contrast agent; and Artirem, a gadoteric acid that ac... [Read more]

Sector Healthcare
Founded 1926
Employees 2,905
Stock Exchange Euronext Paris
Ticker Symbol GBT
Full Company Profile

Financial Performance

Financial Statements